Trials / Sponsors / MapLight Therapeutics
MapLight Therapeutics
Industry · 6 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis Psychosis Associated With Alzheimer's Disease | Phase 2 | 2026-03-25 |
| Not Yet Recruiting | A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia Schizophrenia | Phase 2 | 2026-03-01 |
| Recruiting | A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis Psychosis Associated With Alzheimer's Disease | Phase 2 | 2025-08-15 |
| Recruiting | A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophren Schizophrenia | Phase 2 | 2025-06-27 |
| Enrolling By Invitation | ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD) Autism Spectrum Disorder | Phase 2 | 2023-06-01 |
| Active Not Recruiting | ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD) Autism Spectrum Disorder | Phase 2 | 2022-09-13 |